IRF7 and plasma cell myeloma: Additionally, we inoculated Irf7−/− mice with JEV-Nakayama (GIII), boosted with JEV-Bennett (GII), and administered a final intravenous boost with JEV-Nakayama before splenocyte-myeloma cell fusion.